Risankizumab injector study completed – no major breakthrough expected
NCT ID NCT06937619
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 study tested how well the drug risankizumab (SKYRIZI) is absorbed when given through an on-body injector compared to a standard injection. It involved 263 healthy adults and measured drug levels in the blood and any side effects. The goal was to see if the on-body injector delivers the drug similarly to the usual method, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Risankizumab (SKYRIZI)
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 271954
Grayslake, Illinois, 60030, United States
-
CenExel ACT- Anaheim Clinical Trials /ID# 274805
Anaheim, California, 92801, United States
-
Collaborative Neuroscience Research CNS /ID# 275212
Los Alamitos, California, 90720, United States
-
Cpmi /Id# 274464
Miami, Florida, 33172, United States